Wells Fargo’s SteadyMed Ltd STDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-3,200
Closed -$11K 6683
2017
Q3
$11K Buy
3,200
+2,000
+167% +$10.6K ﹤0.01% 5864
2017
Q2
$8K Hold
1,200
﹤0.01% 5835
2017
Q1
$7K Sell
1,200
-700
-37% -$2.33K ﹤0.01% 5975
2016
Q4
$5K Buy
+1,900
New +$6.47K ﹤0.01% 5969
2016
Q1
Sell
-500
Closed -$2K 6592
2015
Q4
$2K Hold
500
﹤0.01% 6049
2015
Q3
$2K Sell
500
-12,050
-96% -$54.9K ﹤0.01% 6019
2015
Q2
$66K Buy
12,550
+7,450
+146% +$60.2K ﹤0.01% 5236
2015
Q1
$43K Buy
+5,100
New +$43.7K ﹤0.01% 5084

Other funds holding STDY

Wells Fargo's STDY Position: Q4 2017 in Review

Wells Fargo sold out of SteadyMed Ltd (STDY) in Q4 2017, closing a stake of 3,200 shares — an estimated $11K sold.

Wells Fargo first reported a position in STDY in Q1 2015 and held it in 8 quarters. The position peaked at $66K in Q2 2015. 27 funds tracked by Wall St. Rank hold STDY as of Q4 2017.

  • Wells Fargo reported no remaining SteadyMed Ltd position as of Q4 2017 after selling out during the quarter.
  • Wells Fargo sold 3,200 SteadyMed Ltd shares in Q4 2017, an estimated $11K.
  • Wells Fargo first reported a position in SteadyMed Ltd in Q1 2015 and held it in 8 quarters.
  • Wells Fargo's SteadyMed Ltd position peaked at $66K in Q2 2015.
  • 27 funds tracked by Wall St. Rank held SteadyMed Ltd as of Q4 2017.

Based on Wells Fargo's 13F filing for Q4 2017, filed 8 Feb 2018.